Back to Rankings

ABVX

AbivaxC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
View Chart
+
Peers tracked
9
U.S. public peers
Grade Position
In line
vs peer average
ABVX vs peer average
59/100
ABVX vs. peer average (C vs. D)
Grade spread
B 1 · C 5 · F 3
Graded peers loaded
Coverage
9 graded
100% of tracked

Peer overview

ARWR is the first available peer comparator.

Clinical-stage biotech with a market cap near ABVX; useful as a development-stage comparator, though its RNA platform breadth makes it less single-asset-dependent than ABVX.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerARWRArrowhead
ABVX
Abivax
ARWR
Arrowhead
Grade
C
B
Momentum
93
60
Value
41
49
Sentiment
34
60
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive

Grade position vs ARWR

ABVX / ARWR
Grade Position
In line
ABVX vs. peer average (C vs. D)
59/100
Momentum
93
ABVX
Value
41
ARWR
Sentiment
34
ARWR

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ABVX
1
ARWR
ARWR
B
80/100
-1
2
MDGL
MDGL
F
20/100
+2
3
BMRN
BMRN
C
60/100
Even
4
AXSM
Axsome Therapeutics Inc Common
F
20/100
+2
5
RVTY
Revvity Inc Common
C
60/100
Even
ARWR is the first peer returned for this comparison set.